ARCHIVES

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Holland On The Next 10 Years; Progress In Prevention, Diagnosis, Therapy

March 23, 1984

Biology Societies Endorse Cloning Prohibition Act.

February 1, 2002

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

Accrual Picking Up, Still “Nothing To Write Home About;” Unfunded MDs ‘Subsidizing Entire Program”

June 3, 1988